Anixa Biosciences Inc Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Anixa Biosciences Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Anixa Biosciences Inc Net Income (Loss) Attributable to Parent for the quarter ending October 31, 2024 was -$2.88M, a 7.18% decline year-over-year.
  • Anixa Biosciences Inc Net Income (Loss) Attributable to Parent for the twelve months ending October 31, 2024 was -$12.6M, a 28% decline year-over-year.
  • Anixa Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$12.6M, a 28% decline from 2023.
  • Anixa Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$9.81M, a 27.8% increase from 2022.
  • Anixa Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$13.6M, a 4.95% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$12.6M -$2.88M -$193K -7.18% Aug 1, 2024 Oct 31, 2024 10-K 2025-01-10
Q2 2024 -$12.4M -$3.28M -$766K -30.5% May 1, 2024 Jul 31, 2024 10-Q 2024-09-06
Q1 2024 -$11.6M -$3.14M -$851K -37.2% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-04
Q4 2023 -$10.7M -$3.26M -$933K -40.2% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-12
Q3 2023 -$9.81M -$2.69M +$786K +22.6% Aug 1, 2023 Oct 31, 2023 10-K 2025-01-10
Q2 2023 -$10.6M -$2.51M +$235K +8.56% May 1, 2023 Jul 31, 2023 10-Q 2024-09-06
Q1 2023 -$10.8M -$2.29M +$1.26M +35.4% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-04
Q4 2022 -$12.1M -$2.32M +$1.51M +39.4% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-12
Q3 2022 -$13.6M -$3.48M +$537K +13.4% Aug 1, 2022 Oct 31, 2022 10-K 2024-01-16
Q2 2022 -$14.1M -$2.75M +$1.59M +36.6% May 1, 2022 Jul 31, 2022 10-Q 2023-09-06
Q1 2022 -$15.7M -$3.54M -$1.15M -47.7% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 -$14.6M -$3.83M -$1.62M -73.4% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 -$13M -$4.01M -$1.79M -80.4% Aug 1, 2021 Oct 31, 2021 10-K 2023-01-04
Q2 2021 -$11.2M -$4.33M -$1.77M -69.2% May 1, 2021 Jul 31, 2021 10-Q 2022-09-09
Q1 2021 -$9.39M -$2.4M +$241K +9.13% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-10
Q4 2020 -$9.63M -$2.21M +$385K +14.8% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-11
Q3 2020 -$10M -$2.22M Aug 1, 2020 Oct 31, 2020 10-K 2022-01-04
Q2 2020 -$2.56M -$422K -19.7% May 1, 2020 Jul 31, 2020 10-Q 2021-09-01
Q1 2020 -$2.64M Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-10
Q4 2019 -$2.59M Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-11
Q2 2019 -$2.14M +$3.34M +60.9% May 1, 2019 Jul 31, 2019 10-Q 2020-09-08
Q3 2018 -$14M -$5.3M -$5.53M -2478% Aug 1, 2018 Oct 31, 2018 10-K 2019-01-11
Q2 2018 -$8.47M -$5.48M -$3.68M -205% May 1, 2018 Jul 31, 2018 10-Q 2018-09-07
Q1 2018 -$4.79M -$1.38M -$1.54M -959% Feb 1, 2018 Apr 30, 2018 10-Q 2018-06-11
Q4 2017 -$3.25M -$1.84M +$1.76M +48.9% Nov 1, 2017 Jan 31, 2018 10-Q 2018-03-09
Q3 2017 -$5.01M $223K +$1.27M Aug 1, 2017 Oct 31, 2017 10-K 2019-01-11
Q2 2017 -$6.28M -$1.79M -$691K -62.6% May 1, 2017 Jul 31, 2017 10-Q 2018-09-07
Q1 2017 -$5.59M $160K +$1.43M Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-11
Q4 2016 -$7.02M -$3.6M -$2M -126% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-09
Q3 2016 -$5.02M -$1.05M +$245K +18.9% Aug 1, 2016 Oct 31, 2016 10-K 2018-01-09
Q2 2016 -$5.26M -$1.1M +$498K +31.1% May 1, 2016 Jul 31, 2016 10-Q 2017-09-08
Q1 2016 -$5.76M -$1.27M +$965K +43.1% Feb 1, 2016 Apr 30, 2016 10-Q 2017-05-26
Q4 2015 -$6.72M -$1.59M -$5.35M -142% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-16
Q3 2015 -$1.38M -$1.29M +$1.86M +59% Aug 1, 2015 Oct 31, 2015 10-K/A 2016-12-08
Q2 2015 -$3.24M -$1.6M -$2.01M -490% May 1, 2015 Jul 31, 2015 10-Q 2016-08-19
Q1 2015 -$1.23M -$2.24M +$1.01M +31.2% Feb 1, 2015 Apr 30, 2015 10-Q 2016-05-20
Q4 2014 -$2.24M $3.75M +$7.37M Nov 1, 2014 Jan 31, 2015 10-Q 2016-02-19
Q3 2014 -$9.61M -$3.15M -$227K -7.75% Aug 1, 2014 Oct 31, 2014 10-K 2015-12-23
Q2 2014 -$9.38M $411K +$2.99M May 1, 2014 Jul 31, 2014 10-Q 2015-08-18
Q1 2014 -$12.4M -$3.25M -$773K -31.2% Feb 1, 2014 Apr 30, 2014 10-Q 2015-05-22
Q4 2013 -$11.6M -$3.61M -$1.52M -72.5% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-09
Q3 2013 -$10.1M -$2.93M -$1.07M -57.3% Aug 1, 2013 Oct 31, 2013 10-K 2015-01-29
Q2 2013 -$9.01M -$2.58M -$1.95M -310% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 -$7.06M -$2.48M -$1.6M -182% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-16
Q4 2012 -$5.46M -$2.09M -$1.21M -136% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 -$4.25M -$1.86M +$931K +33.3% Aug 1, 2012 Oct 31, 2012 10-K 2013-01-29
Q2 2012 -$5.18M -$629K +$1.14M +64.5% May 1, 2012 Jul 31, 2012 10-Q/A 2013-09-20
Q1 2012 -$6.33M -$877K +$410K +31.9% Feb 1, 2012 Apr 30, 2012 10-Q/A 2013-06-19
Q4 2011 -$6.74M -$886K +$640K +41.9% Nov 1, 2011 Jan 31, 2012 10-Q/A 2013-03-25
Q3 2011 -$7.38M -$2.79M Aug 1, 2011 Oct 31, 2011 10-K 2013-01-29
Q2 2011 -$1.77M -$503K -39.6% May 1, 2011 Jul 31, 2011 10-K 2013-01-29
Q1 2011 -$1.29M Feb 1, 2011 Apr 30, 2011 10-K 2013-01-29
Q4 2010 -$1.53M Nov 1, 2010 Jan 31, 2011 10-K 2013-01-29
Q2 2010 -$1.27M May 1, 2010 Jul 31, 2010 10-Q/A 2011-10-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.